Trials / Conditions / Myeloproliferative Disorder

Myeloproliferative Disorder

22 registered clinical trials studyying Myeloproliferative Disorder — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People NCT07362225	MPN Research Foundation	—
Unknown	Functional Characterization of Thrombopoietin/cMPL Receptor Mutations in Myeloproliferative Neoplasia NCT06246006	Centre Hospitalier Universitaire de Nīmes	—
Recruiting	Cord Blood Transplant in Adults With Blood Cancers NCT05884333	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Haplo Peripheral Blood Sct In GVHD Prevention NCT04473911	Zachariah Michael DeFilipp	Phase 1
Completed	Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. NCT03869476	University Hospital, Angers	N/A
Completed	Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms NCT03808805	University Hospital, Brest	Phase 3
Recruiting	Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Red NCT03852407	University of Liege	Phase 2
Completed	Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoi NCT03734601	Stanford University	Phase 2
Completed	The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase NCT03907436	University of California, Irvine	N/A
Active Not Recruiting	Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression NCT03480360	Dartmouth-Hitchcock Medical Center	Phase 3
Completed	Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation NCT03434730	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (H NCT03149055	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms NCT03688490	University Hospital, Brest	—
Completed	Preventing Stem Cell Transplant Complications With a Blood Separator Machine NCT01866839	National Heart, Lung, and Blood Institute (NHLBI)	Phase 1 / Phase 2
Completed	Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases NCT00909467	Medical University of Graz	—
Completed	Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders NCT00687414	Corewell Health West	—
Completed	Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD NCT00539695	Baylor College of Medicine	Phase 2
Completed	Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metas NCT00588666	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of He NCT00533923	Beth Israel Deaconess Medical Center	Phase 2
Completed	T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies NCT00683046	University of Chicago	Phase 2
Completed	Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies NCT01499147	University of Illinois at Chicago	N/A
Completed	Primary Thrombocythaemia 1 Trial NCT00175838	University of Cambridge	N/A